Ultragenyx Pharmaceutical Inc. (RARE)
Market Closed
17 Jul, 20:00
$
29. 28
-0.94
-3.1105%
$
3.33B Market Cap
- P/E Ratio
- Div Yield
1.5M Volume
-8.23 Eps
$ 30.22
Previous Close 
Want to track RARE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Ultragenyx Pharmaceutical Inc. (RARE) Statistics
Valuation metrics
Market Cap 3.33B
Enterprise value 3.91B
Trailing P/E (ttm) -4.79
Forward P/E -1,907.31
PEG ratio 0.99
Price/Sales (ttm) 4.31
Price/Book (mrq) -12.48
Enterprise Value/Revenue 5.84
Enterprise Value/EBITDA -7.77
Overview
Shares outstanding 96.48M
Float 92.93M
Shares short 11.41M
% Held by insiders 0.03%
% Held by institutions 1.01%
Average volume (10 days) 1.19M
Average volume (90 days) 1.73M
Price summary
52-Week low 18.29
52-Week high 39.89
Beta 0.25
50-Day moving average 26.19
200-Day moving average 23.49
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:3
Last split Date 17 Jan 2014
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -0.91%
Operating margin -0.84%
Operational effectiveness
Return on assets -0.47%
Return on equity 15.67%
Income Statement
Revenue (ttm) 673M
Revenue per share (ttm) 6.65
Quarterly revenue growth (yoy) 0.26%
Gross profit (ttm) -186M
EBITDA -500M
Net income to common (ttm) -575M
Diluted EPS (ttm) -6.06
Quarterly earnings growth (yoy) 0.26%
Balance Sheet
Total cash (mrq) 680M
Total cash per share (mrq) 4.11
Total debt (mrq) 1.25B
Total Debt/Equity (mrq) -5.08
Current ratio (mrq) 2.02%
Book value per share (mrq) -2.28
Cash Flow
Cash flow statement -466M
Levered free cash flow (LFCF) -251.12M
